Stockscreener 앱 받기
2.06
4.83%
0.095
시간 외 거래:
2.16
0.10
+4.85%
전일 마감가:
$1.965
열려 있는:
$2
하루 거래량:
318.61K
Relative Volume:
0.87
시가총액:
$98.25M
수익:
-
순이익/손실:
$-56.85M
주가수익비율:
-
EPS:
-
순현금흐름:
-
1주 성능:
-17.93%
1개월 성능:
-17.27%
6개월 성능:
-70.82%
1년 성능:
+0.00%
1일 변동 폭
$1.91
$2.14
1주일 범위
$1.91
$2.70
52주 변동 폭
$1.74
$13.99
Fractyl Health Inc Stock (GUTS) Company Profile
명칭
Fractyl Health Inc
전화
781-902-8800
주소
3 VAN DE GRAAFF DRIVE, BURLINGTON
GUTS을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
| GUTS | 2.06 | 98.25M | 0 | -56.85M | 0 | 0.00 |
| VRTX | 467.01 | 119.87B | 10.63B | -479.80M | -1.35B | 13.33 |
| REGN | 762.00 | 83.27B | 13.85B | 4.65B | 3.32B | 35.06 |
| ARGX | 567.90 | 33.96B | 1.86B | -40.29M | -1.28B | -4.16 |
| ALNY | 232.27 | 30.18B | 2.09B | -332.26M | 16.06M | -4.14 |
| BNTX | 101.87 | 24.42B | 3.30B | -501.07M | 1.03B | 11.54 |
Fractyl Health Inc Stock (GUTS) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-02-28 | 개시 | Evercore ISI | Outperform |
| 2024-02-27 | 개시 | BofA Securities | Buy |
| 2024-02-27 | 개시 | Morgan Stanley | Overweight |
Fractyl Health Inc 주식(GUTS)의 최신 뉴스
Lee Ainslie's Strategic Reduction in Fractyl Health Inc Holdings - GuruFocus.com
Fractyl Health Third Quarter 2024 Earnings: US$0.48 loss per share (vs US$9.61 loss in 3Q 2023) - Yahoo Finance
Fractyl Health, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com
Fractyl Health president sells $158,540 in stock By Investing.com - Investing.com Canada
Fractyl Health president sells $158,540 in stock - Investing.com
Fractyl Health CEO sells shares worth $238,358 By Investing.com - Investing.com UK
Why This Penny Stock Lost 13% Last Week While Markets Soared - MSN
TSX Venture Composite Index (JX) QuotePress Release - The Globe and Mail
TSX Composite Index (TXCX) QuotePress Release - The Globe and Mail
TSX Real Estate Capped Index (TTRE) QuotePress Release - The Globe and Mail
TSX Composite Dividend Index (TXDC) QuotePress Release - The Globe and Mail
S&P 500 Materials [Sector] (SRMA) QuotePress Release - The Globe and Mail
TSX Utilities Capped Index (TTUT) QuotePress Release - The Globe and Mail
TSX Renewable and Clean Tech Index (TXCT) QuotePress Release - The Globe and Mail
Fractyl Health Reports Third Quarter 2024 Financial Results and Provides Business Updates - The Manila Times
Fractyl Health Q3: Obesity Treatment Progress Despite Widening Losses; $84.7M Cash Runway | GUTS Stock News - StockTitan
Fractyl Health (GUTS) Scheduled to Post Earnings on Tuesday - Defense World
Fractyl Health (GUTS) Set to Announce Earnings on Tuesday - MarketBeat
Fractyl Health nominates GIP/GLP-1 dual agonist as pancreatic gene therapy candidate for obesity - BioWorld Online
Fractyl Health to Present New Preclinical Data on Sustained - GlobeNewswire
Fractyl Health to Present New Preclinical Data on Sustained Weight Maintenance and Blood Sugar from its Rejuva® RJVA-001 Single-Administration GLP-1 Pancreatic Gene Therapy Candidate at ObesityWeek® 2024 - ForexTV.com
Fractyl Health to Present New Preclinical Data on Sustained Weight Maintenance and Blood Sugar - The Bakersfield Californian
Fractyl Health Presented New Analysis from Pooled Data of - GlobeNewswire
Fractyl Health Presented New Analysis from Pooled Data of Revita® Clinical Studies Demonstrating Durable Weight Loss Maintenance for One Year at ObesityWeek® 2024 - StockTitan
SG Americas Securities LLC Invests $33,000 in Fractyl Health, Inc. (NASDAQ:GUTS) - Defense World
Fractyl Health to Report Third Quarter 2024 Financial Results and Provide Business Updates on November 12, 2024 - GlobeNewswire
Fractyl Health to Report Third Quarter 2024 Financial Results and Provide Business Updates on November 12, 2024 - GlobeNewswire Inc.
Fractyl Health to Present Compelling Weight Maintenance - GlobeNewswire
Fractyl Health to Present Compelling Weight Maintenance Data from both Revita® and Rejuva - The Bakersfield Californian
Fractyl Health to Present Compelling Weight Maintenance Data from both Revita® and Rejuva® Platforms at ObesityWeek® 2024 - StockTitan
14,200 Shares in Fractyl Health, Inc. (NASDAQ:GUTS) Bought by Renaissance Technologies LLC - Defense World
Fractyl Health, Inc. (NASDAQ:GUTS) Sees Significant Increase in Short Interest - MarketBeat
Fractyl Health To Debut On Nasdaq Today - RTTNews
Fractyl Health to Present at Chardan’s 8th Annual Genetic Medicines Conference - GlobeNewswire
Financial Fitness Check: Examining Fractyl Health Inc. (GUTS)’s Key Ratios - The Dwinnex
Fractyl Health Inc. (GUTS)’s stock price in review: A technical analysis - US Post News
Massachusetts Financial Services Co. MA Acquires 25,829 Shares of Fractyl Health, Inc. (NASDAQ:GUTS) - Defense World
Fractyl Health president sells over $188k in company stock By Investing.com - Investing.com Canada
Fractyl Health president sells over $188k in company stock - Investing.com India
Jay David Caplan Sells 65,000 Shares of Fractyl Health, Inc. (NASDAQ:GUTS) Stock - MarketBeat
IPO class of 2024 shows value recovery despite mixed stock performance - BioWorld Online
Fractyl Health stock down 8% following $110M IPO - MSN
Fractyl Health to Participate in Upcoming September Investor Conferences - StockTitan
Fractyl Health, Inc. (NASDAQ:GUTS) Short Interest Down 13.2% in August - MarketBeat
Fractyl Health Inc. (GUTS) Stock: A 52-Week Tale of Drops and Gains - The InvestChronicle
Fractyl Health Inc. (GUTS) can make a big difference with a little luck - SETE News
Fractyl Health Inc. (GUTS) presents a great opportunity, but the stock is slightly undervalued - US Post News
Stock Performance Spotlight: Fractyl Health Inc. (GUTS) Ends the Day at 3.58, Up by 6.23 - The Dwinnex
Investing in Fractyl Health Inc. (GUTS) might be an excellent idea, but the stock is currently overvalued/undervalued - US Post News
Fractyl Health Inc. (GUTS) Stock: The Story of a 52-Week Stock Range - The InvestChronicle
Short Interest in Fractyl Health, Inc. (NASDAQ:GUTS) Expands By 5.7% - MarketBeat
Fractyl Health Inc (GUTS) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Fractyl Health Inc 주식 (GUTS) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Rajagopalan Harith | Chief Executive Officer |
Nov 11 '24 |
Sale |
2.47 |
96,517 |
238,358 |
491,329 |
| Caplan Jay David | President, Chief Product Off. |
Nov 10 '24 |
Option Exercise |
0.00 |
187,257 |
0 |
217,741 |
| Caplan Jay David | President, Chief Product Off. |
Nov 11 '24 |
Sale |
2.47 |
64,197 |
158,541 |
153,544 |
| Caplan Jay David | President, Chief Product Off. |
Sep 12 '24 |
Option Exercise |
1.70 |
95,484 |
162,323 |
95,484 |
| Caplan Jay David | President, Chief Product Off. |
Sep 12 '24 |
Sale |
2.90 |
65,000 |
188,474 |
30,484 |
3.66%
1.11%
자본화:
|
볼륨(24시간):